DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,040.00
+135.00 (2.75%)
Feb 21, 2025, 9:00 AM KST
DongKoo Bio & Pharma Revenue
DongKoo Bio & Pharma had revenue of 66.18B KRW in the quarter ending September 30, 2024, with 25.19% growth. This brings the company's revenue in the last twelve months to 253.71B, up 25.78% year-over-year. In the year 2023, DongKoo Bio & Pharma had annual revenue of 215.69B with 10.62% growth.
Revenue (ttm)
253.71B
Revenue Growth
+25.78%
P/S Ratio
0.55
Revenue / Employee
665.91M
Employees
381
Market Cap
137.60B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 57.73T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Celltrion | 2,876.25B |
| Kia Corporation | 104.63T |
| NAVER | 10.39T |